A Single-centre, Randomised, Double-blind, Placebo-controlled, Two-part Study to Assess Safety, Tolerability, Pharmacokinetics of Orally Administered AZD1386.

Trial Profile

A Single-centre, Randomised, Double-blind, Placebo-controlled, Two-part Study to Assess Safety, Tolerability, Pharmacokinetics of Orally Administered AZD1386.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2010

At a glance

  • Drugs AZD 1386 (Primary) ; Naproxen
  • Indications Gastro-oesophageal reflux; Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Dec 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 09 Dec 2010 Actual end date changed from Dec 2009 to Sep 2009 as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Actual number of patients (11) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top